These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2674845)

  • 1. [Significance of seemingly intact urothelium in patients with bladder cancer].
    Kolozsy Z; Mohácsi L; Dauda G; Samodai L; Endresz KF; Tóth A
    Orv Hetil; 1989 Sep; 130(36):1925-6, 1929-31. PubMed ID: 2674845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of denuded urothelium in bladder biopsy.
    Levi AW; Potter SR; Schoenberg MP; Epstein JI
    J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on multiple mucosal biopsy in patients with bladder cancer. 2. Evaluation on the relationship between the results of multiple mucosal biopsy and recurrence, and the clinical course of cases with carcinoma in situ and micro-invasion of carcinoma in situ].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1633-47. PubMed ID: 3825813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iatrogenic tumor cell implantation in bladder cancer].
    Mack D; Rammal E; Jakse G
    Urologe A; 1988 Mar; 27(2):99-104. PubMed ID: 3376373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinoma in situ in multiple mucosal biopsies in patients with bladder tumors].
    Letzeyer W; Rübben H; Dahm HH
    Helv Chir Acta; 1982 Aug; 49(3-4):335-7. PubMed ID: 7129899
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dysplastic urothelial changes in patients with bladder cancer].
    Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
    Urologe A; 1984 Sep; 23(5):281-4. PubMed ID: 6542270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis, prognosis and therapeutic results in urothelial dysplasia in patients with bladder cancer].
    Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
    Orv Hetil; 1984 Jul; 125(31):1875-8, 1881. PubMed ID: 6472835
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dedifferentiated superficial bladder cancer with invasion of the lamina propria (pT1 GIII)].
    Flamm J
    Z Urol Nephrol; 1986 Sep; 79(9):511-6. PubMed ID: 3788301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
    Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A
    Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens.
    Lapham RL; Grignon D; Ro JY
    Semin Diagn Pathol; 1997 May; 14(2):109-22. PubMed ID: 9179972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.